
|Articles|March 1, 2005
- Volume 0 0
Combo Treatment Provides Relief
Advertisement
Articles in this issue
over 21 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsover 21 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesover 21 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAover 21 years ago
Expo Focuses on Caregiver Needsover 21 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsover 21 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004over 21 years ago
Rx.com Offers Alternative to PBM Mail Orderover 21 years ago
Americans Rate US Health Care as Poorover 21 years ago
Pharmacy Security Combo Pack Now Availableover 21 years ago
IOM Advocates Tougher Supplement StandardsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































